Form 8-K - Current report:
SEC Accession No. 0001558370-21-000248
Filing Date
2021-01-19
Accepted
2021-01-19 07:15:44
Documents
47
Period of Report
2021-01-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20210119x8k.htm   iXBRL 8-K 47332
2 EX-99.1 acrs-20210119xex99d1.htm EX-99.1 47202
3 EX-99.2 acrs-20210119xex99d2.htm EX-99.2 24701
4 GRAPHIC acrs-20210119xex99d1g001.jpg GRAPHIC 123805
5 GRAPHIC acrs-20210119xex99d1g002.jpg GRAPHIC 234326
6 GRAPHIC acrs-20210119xex99d1g003.jpg GRAPHIC 169771
7 GRAPHIC acrs-20210119xex99d1g004.jpg GRAPHIC 177886
8 GRAPHIC acrs-20210119xex99d1g005.jpg GRAPHIC 165147
9 GRAPHIC acrs-20210119xex99d1g006.jpg GRAPHIC 148692
10 GRAPHIC acrs-20210119xex99d1g007.jpg GRAPHIC 164000
11 GRAPHIC acrs-20210119xex99d1g008.jpg GRAPHIC 116322
12 GRAPHIC acrs-20210119xex99d1g009.jpg GRAPHIC 65749
13 GRAPHIC acrs-20210119xex99d1g010.jpg GRAPHIC 60639
14 GRAPHIC acrs-20210119xex99d1g011.jpg GRAPHIC 109901
15 GRAPHIC acrs-20210119xex99d1g012.jpg GRAPHIC 122362
16 GRAPHIC acrs-20210119xex99d1g013.jpg GRAPHIC 78511
17 GRAPHIC acrs-20210119xex99d1g014.jpg GRAPHIC 87847
18 GRAPHIC acrs-20210119xex99d1g015.jpg GRAPHIC 83187
19 GRAPHIC acrs-20210119xex99d1g016.jpg GRAPHIC 92605
20 GRAPHIC acrs-20210119xex99d1g017.jpg GRAPHIC 74671
21 GRAPHIC acrs-20210119xex99d1g018.jpg GRAPHIC 71185
22 GRAPHIC acrs-20210119xex99d1g019.jpg GRAPHIC 82323
23 GRAPHIC acrs-20210119xex99d1g020.jpg GRAPHIC 132160
24 GRAPHIC acrs-20210119xex99d1g021.jpg GRAPHIC 133442
25 GRAPHIC acrs-20210119xex99d1g022.jpg GRAPHIC 147481
26 GRAPHIC acrs-20210119xex99d1g023.jpg GRAPHIC 61716
27 GRAPHIC acrs-20210119xex99d1g024.jpg GRAPHIC 145606
28 GRAPHIC acrs-20210119xex99d1g025.jpg GRAPHIC 72323
29 GRAPHIC acrs-20210119xex99d1g026.jpg GRAPHIC 124897
30 GRAPHIC acrs-20210119xex99d1g027.jpg GRAPHIC 124586
31 GRAPHIC acrs-20210119xex99d1g028.jpg GRAPHIC 87106
32 GRAPHIC acrs-20210119xex99d1g029.jpg GRAPHIC 124331
33 GRAPHIC acrs-20210119xex99d1g030.jpg GRAPHIC 138357
34 GRAPHIC acrs-20210119xex99d1g031.jpg GRAPHIC 121500
35 GRAPHIC acrs-20210119xex99d1g032.jpg GRAPHIC 137141
36 GRAPHIC acrs-20210119xex99d2001.jpg GRAPHIC 6032
  Complete submission text file 0001558370-21-000248.txt   5477783

Data Files

Seq Description Document Type Size
37 EX-101.SCH acrs-20210119.xsd EX-101.SCH 3039
38 EX-101.LAB acrs-20210119_lab.xml EX-101.LAB 16068
39 EX-101.PRE acrs-20210119_pre.xml EX-101.PRE 10375
40 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20210119x8k_htm.xml XML 4846
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 21533915
SIC: 2834 Pharmaceutical Preparations